Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

ARV-110 is a proteolysis-targeting chimera (PROTAC) that contains a cereblon ligand 1-derivative connected to an androgen receptor (AR) ligand by a linker region.1 It reduces AR levels in VCaP prostate cancer cells in a time- and concentration-dependent manner. ARV-110 (1 µM) decreases VCaP cancer cell proliferation. In vivo, ARV-110 reduces tumor volume in a VCaP prostate cancer xenograft model that is resistant to the non-steroidal AR antagonist enzalutamide (Item No. 11596).
WARNING This product is not for human or veterinary use.
1. Methods of treating prostate cancer. (2020).